# Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects

> **NCT02641301** · PHASE4 · UNKNOWN · sponsor: **Hopital Lariboisière** · enrollment: 24 (actual)

## Conditions studied

- Bypass Complications

## Interventions

- **DRUG:** Sustained release morphine sulfate, 30 mg

## Key facts

- **NCT ID:** NCT02641301
- **Lead sponsor:** Hopital Lariboisière
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02641301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02641301, "Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02641301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*